Professor University Of Glasgow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dapagliflozin reduces the risks of death and cardiovascular events in patients with heart failure regardless of ejection fraction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2022.

United kingdomPardeep jhundEmily hendersonProfessor university of glasgowHot lineStudy authorProfessor universityHeart failure